The global sepsis diagnostics market is expected to exhibit a strong 8% CAGR over the forecast period from 2016 to 2022, according to the latest research report from Market Research Future (MRFR). The global sepsis diagnostics market is mainly driven by the growing demand for early diagnosis of sepsis and the growing prevalence of sepsis, especially in developing economies. The global sepsis diagnostics market is profiled in detail in the report, which includes a detailed analysis of the major drivers and restraints affecting the market. The major competitive trends in the global sepsis diagnostics market are also analyzed in the report, providing readers a clear overview of the competitive landscape and the key players operating in the sepsis diagnostics market.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2110
Sepsis is a condition caused by a disproportionate reaction by the immunity system to infections and diseases. Normally, the immune system sends out a specific volume and specific types of chemicals to fight infections. Sometimes, these chemicals can trigger inflammation throughout the body, leading to widespread organ damage. This condition can prove to be highly dangerous and can also be fatal, as multiple organ systems can fail due to septic conditions, leading to death. Sepsis is mainly observed in patients with a weakened immune system, patients with cancer, liver or kidney diseases, or severe wounds.
The growing prevalence of hospital-acquired infections has led to a growing awareness about sepsis. This has enabled steady research efforts in the area of sepsis diagnostics, as doctors have come to recognize the importance of catching the condition early, when it can be treated most effectively. This is likely to be a major driver for the global sepsis diagnostics market.
Leading players in the global sepsis diagnostics market include Sandstone Diagnostics Inc., Cube Dx GmbH, Axis-Shield Diagnostics Ltd., Becton Dickinson and Company, T2 Biosystems Inc., Immunexpress, EKF Diagnostics, and bioMerieux Inc. Leading players in the global sepsis diagnostics market are likely to focus on product development in the coming years, as the growing demand for new, faster sepsis diagnosis tests is likely to be a major factor in the sepsis diagnostics market over the forecast period. Acquisition activity is also likely to be high in the sepsis diagnostics market over the forecast period, as leading players may look to acquire smaller players with a promising research portfolio in order to expand their coverage.
In September 2019, Swiss diagnostics company Abionics published the results of a successful test examining the pros and cons of a new diagnostic method for sepsis. The test, conducted on 300 intensive care patients with a high risk of sepsis, reduced diagnosis times from the conventional 24 hours to a mere five minutes. Research advancements such as these are likely to be a crucial factor in the global sepsis diagnostics market in the coming years, as the development of the biotechnology field has led to easy development of faster and more reliable sepsis diagnostic tests.
The global sepsis diagnostics market is segmented on the basis of technology, type, end use, and region.
By technology, the global sepsis diagnostics market is segmented into molecular diagnostics, biomarkers, immunoassays, and others.
By type, the global sepsis diagnostics market is segmented into kits, instruments, blood culture media, and others.
By end use, the global sepsis diagnostics market is segmented into pathology laboratories, specialty clinics, hospitals, diagnostic centers, and others.
North America is the largest regional market for sepsis diagnostics, followed by Europe and Asia Pacific. The growing awareness about hospital-acquired infections in North America has been a key factor driving the regional market’s growth in the coming years. Sepsis is calculated to affect nearly 1.7 million adults in the U.S. every year, leading to more than 250,000 deaths. This is likely to result in growing awareness about sepsis diagnostics technologies. Asia Pacific is likely to exhibit the fastest growth over the forecast period due to the high volume of unmet needs in the region.
Browse Premium Research Report with Tables and Figures @ https://www.marketresearchfuture.com/reports/sepsis-diagnostics-market-2110
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312